BioSpace News Archive

Element Biosciences, Inc., developer of the Element AVITI System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced the formation of its Scientific Advisory Board with four leading experts on genomics, oncology, chemistry, and biology.

Acurx Pharmaceuticals, Inc. announced today certain financial and operational results for the second quarter ended June 30, 2023.

Intensity Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2023, and provided a corporate update.

Antibe Therapeutics Inc. has filed its financial and operating results for the fiscal quarter ended June 30, 2023.

Kura Oncology, Inc. today announced the appointment of Brian Powl as Chief Commercial Officer.

PDS Biotechnology Corporation will discuss its financial results for the quarter ended June 30, 2023 and provide a business update on its conference call today.

Cybin Inc. today reported unaudited financial results for its first quarter ended June 30, 2023, and recent business highlights.

Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) reports financial results for the three and six months ended June 30, 2023, and provides updates on its antiviral pipeline, upcoming milestones and business activities.

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today provided a business update and reported financial results for the second quarter of 2023.

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today reported its financial results for the quarter ended June 30, 2023 and provided a corporate update.